Special Issue "Recent Advances in Amyloid Research: Molecular Biology, Pharmacology, Pathophysiology, Diagnostic Technology, and Therapeutics"
A special issue of Biomedicines (ISSN 2227-9059).
Deadline for manuscript submissions: closed (15 January 2019).
Interests: ATTR amyloidosis; diagnostic technology; biochemical features of amyloid fibrils
Interests: ATTR amyloidosis； biochemical featutes of amyloid fibrils; cell biology; amyloid imaging; therapeutics
Amyloidosis is one of the representative misfolded protein disorders, resulting from intra or extracellular accumulation of amyloid fibrils. While amyloidosis was previously quite an intractable disease, recent basic research on the pathogenesis of several amyloidoses has gradually been able to elucidated several types of amyloidosis, which have become treatable. However, we need more detailed information on amyloidosis and its pathogenesis. Therefore, this Special Issue of Biomedicines will focus on recent advance in amyloid research, including new insights into molecular biology, pharmacology, pathophysiology, and therapeutics. In addition, as it will be more important to make a correct diagnosis in the early stages of the disease after the establishment of effective treatments, submissions regarding new diagnostic procedures are welcome.
Prof. Masahide Yazaki
Prof. Yoshiki Sekijima
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- diagnostic technology
- new therapies
- cell biology
- animal models